[go: up one dir, main page]

WO2004071433A3 - Procedes de traitement de maladie - Google Patents

Procedes de traitement de maladie Download PDF

Info

Publication number
WO2004071433A3
WO2004071433A3 PCT/US2004/003635 US2004003635W WO2004071433A3 WO 2004071433 A3 WO2004071433 A3 WO 2004071433A3 US 2004003635 W US2004003635 W US 2004003635W WO 2004071433 A3 WO2004071433 A3 WO 2004071433A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
methods
compositions
treating disease
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/003635
Other languages
English (en)
Other versions
WO2004071433A2 (fr
Inventor
Robert Zelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scion Pharmaceuticals Inc
Original Assignee
Scion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scion Pharmaceuticals Inc filed Critical Scion Pharmaceuticals Inc
Publication of WO2004071433A2 publication Critical patent/WO2004071433A2/fr
Publication of WO2004071433A3 publication Critical patent/WO2004071433A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés de guanidinyle substitué, des compositions contenant ces composés, et des procédés utilisant ces composés et les compositions à base de ces composés. Les composés, les compositions et les procédés décrits dans cette invention peuvent être utilisés dans la modulation thérapeutique de la fonction d'un canal ionique, et dans le traitement de maladies et de symptômes de maladie, notamment ceux induits par certaines cibles de sous-type de canal de calcium.
PCT/US2004/003635 2003-02-11 2004-02-09 Procedes de traitement de maladie Ceased WO2004071433A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44660303P 2003-02-11 2003-02-11
US60/446,603 2003-02-11

Publications (2)

Publication Number Publication Date
WO2004071433A2 WO2004071433A2 (fr) 2004-08-26
WO2004071433A3 true WO2004071433A3 (fr) 2004-11-25

Family

ID=32869537

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/003635 Ceased WO2004071433A2 (fr) 2003-02-11 2004-02-09 Procedes de traitement de maladie

Country Status (1)

Country Link
WO (1) WO2004071433A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614630A (en) * 1991-02-08 1997-03-25 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614630A (en) * 1991-02-08 1997-03-25 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers

Also Published As

Publication number Publication date
WO2004071433A2 (fr) 2004-08-26

Similar Documents

Publication Publication Date Title
WO2005086836A3 (fr) Modulateurs de canal ionique
WO2005086895A3 (fr) Modulateurs de la fonction canal ionique
WO2008033562A3 (fr) Composés inhibiteurs de kinases
WO2006086562A3 (fr) Derives de phenylazetidinone
EA200700225A1 (ru) Аналоги тетрапептида
WO2006042249A3 (fr) Methodes et compositions de traitement de la douleur de migraine
ZA200703002B (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
WO2004100881A3 (fr) Preparation et utilisation de derives d'aryl alkyl acide pour le traitement de l'obesite
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2007016538A3 (fr) Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
WO2006102504A3 (fr) Combinaisons destinees au traitement de cancer
WO2005086902A3 (fr) Modulateurs de canal ionique
MX2007005590A (es) Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
BRPI0508537A (pt) moduladores do canal de ìon
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2005097112A3 (fr) Modulateurs de canaux ioniques
WO2006009975A3 (fr) Utilisation d'histamine et de composes associes pour traiter des troubles de la fonction musculaire
WO2004073615A8 (fr) Composes de deazaflavine et leurs methodes d'utilisation
WO2004087880A8 (fr) Composes et leur utilisation dans le traitement du diabete et troubles connexes
WO2003072053A3 (fr) Composes pour le traitement de la surcharge en cuivre
WO2004060878A3 (fr) Inhibiteurs de phosphatases
BRPI0508550A (pt) moduladores de canal de ìon
WO2006113718A3 (fr) Compositions destinees au traitement des neoplasmes
WO2005112923A3 (fr) Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase